AU2004268381B2 - Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep - Google Patents

Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep Download PDF

Info

Publication number
AU2004268381B2
AU2004268381B2 AU2004268381A AU2004268381A AU2004268381B2 AU 2004268381 B2 AU2004268381 B2 AU 2004268381B2 AU 2004268381 A AU2004268381 A AU 2004268381A AU 2004268381 A AU2004268381 A AU 2004268381A AU 2004268381 B2 AU2004268381 B2 AU 2004268381B2
Authority
AU
Australia
Prior art keywords
day
oxcarbazepine
sleep
pain
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2004268381A
Other languages
English (en)
Other versions
AU2004268381A1 (en
Inventor
Donald Manning
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0320637A external-priority patent/GB0320637D0/en
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU2004268381A1 publication Critical patent/AU2004268381A1/en
Application granted granted Critical
Publication of AU2004268381B2 publication Critical patent/AU2004268381B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2004268381A 2003-09-03 2004-09-02 Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep Ceased AU2004268381B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0320637.2 2003-09-03
GB0320637A GB0320637D0 (en) 2003-09-03 2003-09-03 Organic compounds
US53737804P 2004-01-16 2004-01-16
US60/537,378 2004-01-16
PCT/EP2004/009797 WO2005020968A2 (en) 2003-09-03 2004-09-02 Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep

Publications (2)

Publication Number Publication Date
AU2004268381A1 AU2004268381A1 (en) 2005-03-10
AU2004268381B2 true AU2004268381B2 (en) 2009-06-18

Family

ID=34276821

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2004268381A Ceased AU2004268381B2 (en) 2003-09-03 2004-09-02 Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep

Country Status (18)

Country Link
US (1) US20060270658A1 (enExample)
EP (1) EP1663247B1 (enExample)
JP (1) JP2007513056A (enExample)
KR (1) KR20060118426A (enExample)
AT (1) ATE446759T1 (enExample)
AU (1) AU2004268381B2 (enExample)
BR (1) BRPI0414112A (enExample)
CA (1) CA2537060A1 (enExample)
DE (1) DE602004023861D1 (enExample)
IL (1) IL173822A0 (enExample)
IS (1) IS8373A (enExample)
MA (1) MA28036A1 (enExample)
MX (1) MXPA06002392A (enExample)
NO (1) NO20061515L (enExample)
RU (1) RU2369393C2 (enExample)
SG (1) SG146631A1 (enExample)
TN (1) TNSN06072A1 (enExample)
WO (1) WO2005020968A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060252745A1 (en) 2005-05-06 2006-11-09 Almeida Jose L D Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
GB0603008D0 (en) * 2006-02-14 2006-03-29 Portela & Ca Sa Method
ES2396051T3 (es) * 2006-04-26 2013-02-18 Supernus Pharmaceuticals, Inc. Preparaciones de liberación controlada de oxcarbazepina que tienen perfil de liberación sigmoidal
GB0700773D0 (en) 2007-01-15 2007-02-21 Portela & Ca Sa Drug therapies
KR102486435B1 (ko) 2022-04-25 2023-01-10 주식회사 제이비플랜트 산업용 냉동기기의 친환경 패널의 제조 방법

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001032183A2 (en) * 1999-11-02 2001-05-10 Novartis Ag Pharmaceutical compositions comprising oxcarbazepine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH500196A (de) 1969-03-10 1970-12-15 Ciba Geigy Ag Verfahren zur Herstellung von neuen Azepinderivaten
US4353887A (en) 1979-08-16 1982-10-12 Ciba-Geigy Corporation Divisible tablet having controlled and delayed release of the active substance
CO4920215A1 (es) 1997-02-14 2000-05-29 Novartis Ag Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones
GB9930058D0 (en) 1999-12-20 2000-02-09 Novartis Ag Organic compounds
GB0128674D0 (en) * 2001-11-30 2002-01-23 Boots Co Plc Treatment of sleep disorders and the like
JP2006509735A (ja) * 2002-10-17 2006-03-23 ノバルティス アクチエンゲゼルシャフト オクスカルバゼピンまたはその誘導体およびｃｏｘ２インヒビターからなる疼痛処置用医薬組成物

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001032183A2 (en) * 1999-11-02 2001-05-10 Novartis Ag Pharmaceutical compositions comprising oxcarbazepine

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Carrazana et al. Journal of Pain and Symptom Management (2003) vol. 25, no. 5 pages S31-S35 *
Schmader et al. Clinical Journal of Pain vol 18, no. 6 (2002) pages 350-354 *

Also Published As

Publication number Publication date
WO2005020968A2 (en) 2005-03-10
RU2006110550A (ru) 2007-12-20
EP1663247B1 (en) 2009-10-28
TNSN06072A1 (en) 2007-10-03
JP2007513056A (ja) 2007-05-24
RU2369393C2 (ru) 2009-10-10
IL173822A0 (en) 2006-07-05
CA2537060A1 (en) 2005-03-10
KR20060118426A (ko) 2006-11-23
ATE446759T1 (de) 2009-11-15
AU2004268381A1 (en) 2005-03-10
NO20061515L (no) 2006-06-06
BRPI0414112A (pt) 2006-10-31
WO2005020968A3 (en) 2005-05-19
SG146631A1 (en) 2008-10-30
US20060270658A1 (en) 2006-11-30
DE602004023861D1 (de) 2009-12-10
MA28036A1 (fr) 2006-07-03
EP1663247A2 (en) 2006-06-07
MXPA06002392A (es) 2006-06-20
IS8373A (is) 2006-03-24

Similar Documents

Publication Publication Date Title
TW389696B (en) Accelerated release composition containing bromocriptine
CA2500662A1 (en) Dosage escalation and divided daily dose of anti-depressants to treat neurological disorders
KR20200055067A (ko) 성인의 초점성 뇌전증의 치료를 위한 합성 경피성 칸나비디올
AU2002340971B2 (en) Use of 2-oxo-1-pyrrolidine derivatives for the treatment of dyskinesia and movement disorders
US20210353559A1 (en) Composition and method for treating neurological disease
AU2009304002B9 (en) A medicinal product and treatment
US10500170B2 (en) Composition and method for treating neurological disease
AU2004268381B2 (en) Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep
US11833121B2 (en) Composition and method for treating neurological disease
CA2480275A1 (en) Statin therapy for enhancing cognitive maintenance
ZA200601502B (en) Use of oxcarbazepine for the treatment of diabetic neuropathic pain and improvement of sleep
HUP0300717A2 (hu) Mirtazapint és paracetamolt vagy nem szteroid gyulladáscsökkentő gyógyszert tartalmazó gyógyszerkombináció fejfájás kezelésére
MX2011013989A (es) Combinacion farmaceutica.
US6977253B2 (en) Methods for the treatment of bipolar disorder using carbamazepine
US20230028539A1 (en) Pharmaceutical composition, complementary kit and application thereof
US20060094709A1 (en) Methods for the treatment of bipolar disorder using carbamazepine
AU2013336683A1 (en) Drug combinations containing statins for treating cardiovascular diseases

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired